Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients

This single‐centre retrospective observational study analysed the efficacy of retreatment with immunomodulatory agents (IMiDs) and proteasome inhibitors (PIs) after treatment with daratumumab monotherapy in patients with relapsed and/or refractory multiple myeloma (RRMM). In total 55 patients were t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Haematol
Asıl Yazarlar: Oostvogels, Rimke, Jak, Margot, Raymakers, Reinier, Mous, Rogier, Minnema, Monique C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Haematological Malignancy
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6220946/
https://ncbi.nlm.nih.gov/pubmed/30080247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15504
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller